Advertisement

Topics

First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study

20:01 EDT 16 Apr 2018 | Cancer Connect

CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with […]

The post First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study appeared first on .

Original Article: First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study

NEXT ARTICLE

More From BioPortfolio on "First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...